ST6GAL1 and familial pancreatic carcinoma: In breast cancer, ST6GAL1 can promote TGFβ-induced EMT as well as maintenance of a mesenchymal state [93], and in pancreatic cancer, ST6GAL1-mediated sialylation can upregulate mesenchymal markers and enhance cell invasion [168].